Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002374:Catalase / Q000032:analysis; D003470:Culture Media; D004352:Drug Resistance, Microbial / Q000187:drug effects*; D004977:Ethambutol / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D006168:Guinea Pigs; D007538:Isoniazid / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008168:Lung / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000472:pathogenicity*; D013154:Spleen / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D003470:Culture Media; D007612:Kanamycin; D004977:Ethambutol; D002374:Catalase; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin